Larimar Therapeutics shares are trading higher after Leerink Partners initiated coverage on the stock with an Outperform rating and $25 price target.

LARIMAR THERAPEUTICS INC +2.35%

LARIMAR THERAPEUTICS INC

LRMR

6.53

+2.35%

Larimar Therapeutics shares are trading higher after Leerink Partners initiated coverage on the stock with an Outperform rating and $25 price target.
Every question you ask will be answered
Scan the QR code to contact us
whatsapp
Also you can contact us via